影視板塊走強 影視行業逐步復甦
格隆匯8月21日丨影視板塊午後拉昇走強,上海電影逼近漲停,華凱創意漲超8%,金逸影視、中國電影、華誼兄弟等跟漲。由管虎執導的抗戰電影《八佰》點映大火,截至昨日點映票房破2億,打破《西遊記女兒國》1.79億的點映票房,創造中國電影市場點映票房最高紀錄。8月20日是影院復工滿月的日子,據國家電影專資辦數據顯示,截至北京時間8月20日0時,全國票房已超10.1億,超3300萬人次觀影。中航證券表示,多部影片陸續定檔,疊加即將到來的情人節、國慶檔期效應,電影市場加速提振。國信證券稱,8月份開始新片數量、質量顯著提升,同時部分省市亦開始放鬆對上座率等條件限制,有望加速電影市場復甦進度;同時在前期積累較多優質新片之下,電影市場恢復進度有望超預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.